Sarah Gillett, M.D., Ph.D.

Assistant Professor of Medicine, Hematology and Oncology

Medical Oncologist, UVM Health Network

A person with blonde hair and a polka dot shirt
Alma mater(s)
  • B.S., Tufts University
  • M.D,. Larner College of Medicine, University of Vermont
  • Ph.D., University of Vermont
Affiliated Department(s)

University of Vermont Cancer Center

Department of Medicine, Division of Hospital Medicine

Department of Medicine, Division of Hematology and Oncology

Dr. Gillett's UVM Cancer Center Page

 

BIO

Dr. Gillett is is a medical oncologist practicing at the University of Vermont Medical center and a professor in the Hematology and Oncology Division at the Larner College of Medicine. Research interests include patient clinical care, GI oncology, thyroid cancer, clinical trials, and the cognitive effects of cancer treatment. 

Dr. Gillett's postdoctoral training

Residency in Internal Medicine, University of Vermont Health Network

Fellowship in Hematology and Oncology, University of Vermont Health Network

 

 

 

Publications

Dr. Sarah Gillett's Publications

Area(s) of expertise

  • Patient Clinical Care
  • GI oncology
  • Thyroid cancer
  • Clinical trials
  • Cognitive effects of cancer treatment 

Dr. Gillett's recent publications

Hepatocyte growth factor and risk of incident stroke in Black and White Americans in the Reasons for Geographic and Racial Differences in Stroke study.  

Gillett SR, Koh I, Zakai NA, Judd SE, Plante TB, Howard G, Cushman M. 

Res Pract Thromb Haemost. 2024 Feb 8;8(2):102340. doi: 10.1016/j.rpth.2024.102340. eCollection 2024 Feb. 

PMID: 38511198 Free PMC article.  

C-reactive protein and risk of cognitive decline: The REGARDS study.  

Arce Rentería M, Gillett SR, McClure LA, Wadley VG, Glasser SP, Howard VJ, Kissela BM, Unverzagt FW, Jenny NS, Manly JJ, Cushman M. 

PLoS One. 2020 Dec 31;15(12):e0244612. doi: 10.1371/journal.pone.0244612. eCollection 2020. 

PMID: 33382815 Free PMC article.  

Hemostasis biomarkers and incident cognitive impairment: the REGARDS study.  

Gillett SR, McClure LA, Callas PW, Thacker EL, Unverzagt FW, Wadley VG, Letter AJ, Cushman M. 

J Thromb Haemost. 2018 Jul;16(7):1259-1267. doi: 10.1111/jth.14138. Epub 2018 Jun 6. 

PMID: 29733497 Free PMC article.  

N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort.  

Cushman M, Callas PW, McClure LA, Unverzagt FW, Howard VJ, Gillett SR, Thacker EL, Wadley VG. 

J Alzheimers Dis. 2016 Sep 6;54(2):497-503. doi: 10.3233/JAD-160328. 

PMID: 27567834  

Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.  

Gillett SR, Thacker EL, Letter AJ, McClure LA, Wadley VG, Unverzagt FW, Kissela BM, Kennedy RE, Glasser SP, Levine DA, Cushman M. 

Clin Neuropsychol. 2015;29(4):466-86. doi: 10.1080/13854046.2015.1042524. Epub 2015 May 15. 

PMID: 25978342 Free PMC article.  

 
 

Bio

Dr. Gillett is is a medical oncologist practicing at the University of Vermont Medical center and a professor in the Hematology and Oncology Division at the Larner College of Medicine. Research interests include patient clinical care, GI oncology, thyroid cancer, clinical trials, and the cognitive effects of cancer treatment. 

Dr. Gillett's postdoctoral training

Residency in Internal Medicine, University of Vermont Health Network

Fellowship in Hematology and Oncology, University of Vermont Health Network

 

 

 

Areas of Expertise

  • Patient Clinical Care
  • GI oncology
  • Thyroid cancer
  • Clinical trials
  • Cognitive effects of cancer treatment 

Dr. Gillett's recent publications

Hepatocyte growth factor and risk of incident stroke in Black and White Americans in the Reasons for Geographic and Racial Differences in Stroke study.  

Gillett SR, Koh I, Zakai NA, Judd SE, Plante TB, Howard G, Cushman M. 

Res Pract Thromb Haemost. 2024 Feb 8;8(2):102340. doi: 10.1016/j.rpth.2024.102340. eCollection 2024 Feb. 

PMID: 38511198 Free PMC article.  

C-reactive protein and risk of cognitive decline: The REGARDS study.  

Arce Rentería M, Gillett SR, McClure LA, Wadley VG, Glasser SP, Howard VJ, Kissela BM, Unverzagt FW, Jenny NS, Manly JJ, Cushman M. 

PLoS One. 2020 Dec 31;15(12):e0244612. doi: 10.1371/journal.pone.0244612. eCollection 2020. 

PMID: 33382815 Free PMC article.  

Hemostasis biomarkers and incident cognitive impairment: the REGARDS study.  

Gillett SR, McClure LA, Callas PW, Thacker EL, Unverzagt FW, Wadley VG, Letter AJ, Cushman M. 

J Thromb Haemost. 2018 Jul;16(7):1259-1267. doi: 10.1111/jth.14138. Epub 2018 Jun 6. 

PMID: 29733497 Free PMC article.  

N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort.  

Cushman M, Callas PW, McClure LA, Unverzagt FW, Howard VJ, Gillett SR, Thacker EL, Wadley VG. 

J Alzheimers Dis. 2016 Sep 6;54(2):497-503. doi: 10.3233/JAD-160328. 

PMID: 27567834  

Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.  

Gillett SR, Thacker EL, Letter AJ, McClure LA, Wadley VG, Unverzagt FW, Kissela BM, Kennedy RE, Glasser SP, Levine DA, Cushman M. 

Clin Neuropsychol. 2015;29(4):466-86. doi: 10.1080/13854046.2015.1042524. Epub 2015 May 15. 

PMID: 25978342 Free PMC article.